References
- Kenna MA, Rosane BA, Bluestone CD. Medical management of chronic suppurative otitis media without cholesteatoma in children – update. Am J Otol 1993; 14: 469
- Fliss DM, Dagan R, Houri Z, Leiberman A. Medical management of chronic suppurative otitis media without cholesteatoma in children. J Pediatr 1990; 116: 991–6
- Berman S. Otitis media in children. N Engl J Med 1995; 332: 1560–5
- Jung TT. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in the pathogenesis of otitis media. Laryngoscope 1998; 98: 980–93
- Jung TT, Choi K, Park YS, Schlund D. Effect of prostaglandin, leukotriene, and arachidonic acid on experimental otitis media with effusion in chinchillas. Ann Otol Rhinol Laryngol 1990; 99: 28–32
- Decadron. Available from:, , http://www.healthsqare.com/nrwrx/dec1118.htm.
- Baggett HC, Prazma J, Rose AS, Lane AP, Pillsbury HC III. The role of glucocorticoids in endotoxin-mediated otitis media with effusion. Arch Otolaryngol Head Neck Surg 1997; 123: 41–6
- Herman P, Tan CT, Van Den Abbeele T, Escoubet B, Friedlander G, Huy PT. Glucocorticosteroids increase sodium transport in middle ear epithelium. Am J Physiol 1997; 272: 184–90
- Paparella MM, Schachern P. New developments in treating otitis media. Ann Otol Rhinol Laryngol Suppl 1997; 163: 7–10
- Yang JFC. Rimexolone: a new ophthalmic corticosteroid with low intraocular pressure-raising potential. Drugs of Today 1997; 33: 123–9
- Brogden RN. Rimexolone: a review of its pharmacological properties and clinical potential in the management of ocular inflammation. Biodrugs 1997; 8: 66–79
- Fliss DM, Dagan R, Meidan N, Leiberman A. Aerobic bacteriology of chronic suppurative otitis media without cholesteatoma in children. Ann Otol Rhinol Laryngol 1992; 101: 866–9
- Bluestone CD, Stool SE, Kenna MA. Pediatric otolaryngology3rd edn. WB Saunders, Philadelphia 1996
- Johnson MD, Fitzgerald JE, Leonard G, Burleson JA, Kreutzer DL. Cytokines in experimental otitis media with effusion. Laryngoscope 1994; 104: 191–6
- Jung HH, Kim MW, Lee JH, Kim YT, Kim NH, Chang BA, et al. Expression of vascular endothelial growth factor in otitis media. Acta Otolaryngol 1999; 119: 801–8
- Skotnicka B, Hassmann E. Cytokines in children with otitis media with effusion. Eur Arch Otorhinolaryngol 2000; 257: 323–6
- John EO, Russell PT, Nam B, Jinn TH, Jung TT. Concentration of nitric oxide metabolites in middle ear effusion. Int J Pediatr Otorhinolaryngol 2001; 60: 55–8
- Chonmaitree T, Patel JA, Lett-Brown MA, Uchinda TR, Garofalo MJ, Owen VM, et al. Virus and bacteria enhance histamine production in middle ear fluids of children with acute otitis media. J Infect Dis 1994; 169: 1265–70
- Rhee CK, Jung TT, Miller S, Weeks D. Experimental otitis media with effusion induced by platelet activating factor. Ann Otol Rhinol Laryngol 1993; 2: 600–5
- Catanzaro A, Ryan A, Batcher S, Wasserman SI. The response to human rIL-1, rIL-2, and rTNF in the middle ear of guinea pigs. Laryngoscope 1991; 101: 271–5
- Schousboe LP, Ovesen T, Pedersen CB. Middle ear epithelium has inflammatory capacity. Acta Otolaryngol Suppl 2000; 543: 89–91
- Roland PS, Kreisler LS, Reese B, Anon JB, Lanier B, Conroy PJ, et al. Topical ciprofloxacin/dexamethasone otic suspension is superior to oflaxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 2004; 113: 40–6
- Dohar, JE, Wall, M, Roland, PS, Dupre, SJ, Potts, SL, Conroy, PJ, et al. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in AOMT. Poster R507. Am Acad Otolaryngol Head Neck Surg, Los Angeles, September 24, 2005.
- Juhn SK, Jung TT. Inflammatory changes reflected in middle ear effusion in otitis media. Auris Nasus Larynx 1985; 12 Suppl 1: S63–S66